UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: April 19, 2002 Liska Biometry, Inc. (Exact name of registrant as specified in its chapter) Florida (State or other jurisdiction of incorporation 333-94265 (Commission File Number) 061562447 (IRS Employer Identification No.) LISKA BIOMETRY, INC. 6066 Vineyard Drive Ottawa, Ontario Canada K1C 2M5 (Address of principal executive offices) (Zip Code) FTLA, INC. ---------- (Former name or former address, if changed since last report) INFORMATION TO BE INCLUDED IN THE REPORT LISKA BIOMETRY, INC. is also referred to hereafter as "the Company," "we," or "our." Item 1. Changes in Control of Registrant. Not Applicable. Item 2. Acquisition or Disposition of Assets. Not Applicable. Item 3. Bankruptcy or Receivership. Not Applicable. Item 4. Changes in Registrant's Certifying Accountant. Not Applicable. Item 5. Other Events On March 28, 2002, our Board of Directors approved a change of our name from FTLA, Inc. to Liska Biometry, Inc. In connection with the name change, we obtained a new trading symbol which is "LSKA". Our common stock will be quoted under the symbol LSKA beginning April 22, 2002. Item 6. Resignations of Registrant's Directors. Not Applicable. Item 7. Financial Statements and Exhibits. (a) Not Applicable. (b) Not Applicable. (c) Exhibits. None Item 8. Change in Fiscal Year. Not Applicable. Item 9. Regulation FD Disclosure. Not Applicable. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 19, 2002 FTLA, Inc. By /s/ Lam Ko Chau ----------------- CHIEF EXECUTIVE OFFICER AND A DIRECTOR